The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 42 results:
Author Title [ Type(Desc)] Year
Filters: Author is Efstratiou, Ioannis  [Clear All Filters]
Journal Article
Doumas, A., Dionyssopoulos A., Christoforidis T., Papaconstantinou A., Efstratiou I., Iakovou I., et al. (2010).  Is 0.75 mm Breslow thickness the correct cut-off point for performing sentinel node biopsy in patients with melanoma?. Hell J Nucl Med. 13(3), 253-6.
Iliadis, A., Pazarli E., Chytoudis-Peroudis C-C., Chondromatidou S., Tsitouridis I., Efstratiou I., et al. (2018).  A 74-Year-Old Female with a Well Circumscribed Parietal Lobe Mass.. Brain Pathol. 28(3), 437-438.
Kotoula, V., Bobos M., Alexopoulou Z., Papadimitriou C., Papadopoulou K., Charalambous E., et al. (2014).  Adjusting breast cancer patient prognosis with non-HER2-gene patterns on chromosome 17.. PLoS One. 9(8), e103707.
Koletsa, T., Stavridi F., Bobos M., Kostopoulos I., Kotoula V., Eleftheraki A. G., et al. (2014).  alphaB-crystallin is a marker of aggressive breast cancer behavior but does not independently predict for patient outcome: a combined analysis of two randomized studies.. BMC Clin Pathol. 14, 28.
Pentheroudakis, G., Kotoula V., Koliou G-A., Karavasilis V., Samantas E., Aravantinos G., et al. (2018).  AMALTHEA: Prospective, Single-Arm Study of the Hellenic Cooperative Oncology Group (HeCOG) Evaluating Efficacy and Safety of First-Line FOLFIRI + Aflibercept for 6 Months Followed by Aflibercept Maintenance in Patients With Metastatic Colorectal Cancer.. Clin Colorectal Cancer. 17(4), e631-e637.
Pentheroudakis, G., Mavroeidis L., Papadopoulou K., Koliou G-A., Bamia C., Chatzopoulos K., et al. (2019).  Angiogenic and Antiangiogenic VEGFA Splice Variants in Colorectal Cancer: Prospective Retrospective Cohort Study in Patients Treated With Irinotecan-Based Chemotherapy and Bevacizumab.. Clin Colorectal Cancer. 18(4), e370-e384.
Pentheroudakis, G., Kotoula V., De Roock W., Kouvatseas G., Papakostas P., Makatsoris T., et al. (2013).  Biomarkers of benefit from cetuximab-based therapy in metastatic colorectal cancer: interaction of EGFR ligand expression with RAS/RAF, PIK3CA genotypes.. BMC Cancer. 13, 49.
Kyriakou, A., Patsatsi A., Papadopoulos V., Kioumi A., Efstratiou I., & Lazaridou E. (2019).  A case of palisaded neutrophilic granulomatous dermatitis with subsequent development of chronic myelomonocytic leukemia.. Clin Case Rep. 7(4), 695-698.
Mountzios, G., Aivazi D., Kostopoulos I., Kourea H. P., Kouvatseas G., Timotheadou E., et al. (2014).  Differential expression of the insulin-like growth factor receptor among early breast cancer subtypes.. PLoS One. 9(3), e91407.
Patsatsi, A., Kyriakou A., Nasr A., Efstratiou I., & Sotiriadis D. (2014).  Disseminated waxy papules: a sign of systemic disease.. Cutis. 94(1), E3-4.
Chrisoulidou, A., Pazaitou-Panayiotou K., Georgiou E., Boudina M., Kontogeorgos G., Iakovou I., et al. (2008).  Ectopic Cushing's syndrome due to CRH secreting liver metastasis in a patient with medullary thyroid carcinoma.. Hormones (Athens). 7(3), 259-62.
Razis, E., Pentheroudakis G., Rigakos G., Bobos M., Kouvatseas G., Tzaida O., et al. (2014).  EGFR gene gain and PTEN protein expression are favorable prognostic factors in patients with KRAS wild-type metastatic colorectal cancer treated with cetuximab.. J Cancer Res Clin Oncol. 140(5), 737-48.
Zarkavelis, G., Kotoula V., Kolliou G-A., Papadopoulou K., Tikas I., Karavasilis V., et al. (2019).  Genetic mapping of pancreatic cancer by targeted next-generation sequencing e. ESMO Open. 4(5), e000525.
Linardou, H., Kotoula V., Kouvatseas G., Mountzios G., Karavasilis V., Samantas E., et al. (2019).  Genotyping and Mutations in Greek Patients With Non-small-cell Lung Cancer: Incidence, Significance and Implications for Treatment.. Cancer Genomics Proteomics. 16(6), 531-541.
Kalabalikis, D., Patsatsi A., Trakatelli M-G., Efstratiou I., & Sotiriadis D. (2010).  Hemorrhagic bullae and skin fragility--a clinicopathologic challenge.. Int J Dermatol. 49(1), 21-3.
Kalabalikis, D., Patsatsi A., Trakatelli M-G., Pitsari P., Efstratiou I., & Sotiriadis D. (2010).  Hyperpigmented forearms and nail: a quiz.. Acta Derm Venereol. 90(6), 657-9.
Kourea, H. P., Kotoula V., Koutras A., Alexopoulou Z., Papaspirou I., Skarlos D. V., et al. (2015).  Impact of tumor angiogenic profile on the outcome of patients with metastatic breast carcinoma treated with weekly docetaxel. A Hellenic Cooperative Oncology Group (HeCOG) study.. Histol Histopathol. 30(9), 1129-41.
Kotoula, V., Bobos M., Vassilakopoulou M., Tsolaki E., Chrisafi S., Psyrri A., et al. (2015).  Intact or broken-apart RNA: an alternative concept for ALK fusion screening in non-small cell lung cancer (NSCLC).. Appl Immunohistochem Mol Morphol. 23(1), 60-70.
Lakis, S., Dimoudis S., Kotoula V., Alexopoulou Z., Kostopoulos I., Koletsa T., et al. (2016).  Interaction Between Beta-Catenin and EGFR Expression by Immunohistochemistry Identifies Prognostic Subgroups in Early High-risk Triple-negative Breast Cancer.. Anticancer Res. 36(5), 2365-78.
Polychronidou, G., Kotoula V., Manousou K., Kostopoulos I., Karayannopoulou G., Vrettou E., et al. (2018).  Mismatch repair deficiency and aberrations in the Notch and Hedgehog pathways are of prognostic value in patients with endometrial cancer.. PLoS One. 13(12), e0208221.
Papadopoulou, M., Panagopoulou P., Papadopoulou A., Hatzipantelis E., Efstratiou I., Galli-Tsinopoulou A., et al. (2018).  The multiple faces of Langerhans cell histiocytosis in childhood: A gentle reminder.. Mol Clin Oncol. 8(3), 489-492.
Nellas, K., Konstantinidis I., Zevgaridis A., Printza A., & Efstratiou I. (2009).  Nasal mucosal melanoma presenting as central type vertigo: a case report.. Cases J. 2, 7149.
Lazaridis, G., Kotoula V., Vrettou E., Kostopoulos I., Manousou K., Papadopoulou K., et al. (2019).  Opposite Prognostic Impact of Single PTEN-loss and Mutations in Early High-risk Breast Cancer.. Cancer Genomics Proteomics. 16(3), 195-206.
Fountzilas, G., Kourea H. P., Bobos M., Televantou D., Kotoula V., Papadimitriou C., et al. (2011).  Paclitaxel and bevacizumab as first line combined treatment in patients with metastatic breast cancer: the Hellenic Cooperative Oncology Group experience with biological marker evaluation.. Anticancer Res. 31(9), 3007-18.
Koumarianou, A., Karayannopoulou G., Gourgioti G., Batistatou A., Bobos M., Efstratiou I., et al. (2015).  PAI-1 and HER2 interaction in advanced breast cancer disease: evidence for added benefit from trastuzumab in HER2-negative patients.. Cancer Chemother Pharmacol. 75(6), 1289-301.

Pages

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.